https://www.asawaldstein.com/press/compliance-as-a-competitive-edge-for-pet-supplement%2C-treat-companies 2026-04-13 https://www.asawaldstein.com/press/a-new-generation-of-energy%3A-are-pouches-the-next-%E2%80%98big-thing%E2%80%99-in-active-nutrition%3F 2026-02-06 https://www.asawaldstein.com/press/compliance-in-the-digital-age%3A-navigating-enforcement%2C-marketing-risks%2C-and-the-rise-of-ai-%7C-state-of-the-supplement-industry 2025-12-05 https://www.asawaldstein.com/press/ssg-2025%3A-asa-waldstein-on-fda%2C-ftc-and-nad-enforcement-trends 2025-11-25 https://www.asawaldstein.com/press/nad%2B-health-ads-scrutinized-as-nad-recommends-reus-research-modify-or-discontinue-certain-claims 2025-11-05 https://www.asawaldstein.com/press/kisc-my-health-radio-show-with-captain-cran-man-stephen-lukawski-with-asa-waldstein-and-cohost-peter-mingils 2025-11-04 https://www.asawaldstein.com/press/fda-warning-letter-trends%3A-third-party-reviews%2C-eye-products%2C-'made-in-usa'-claims 2025-10-16 https://www.asawaldstein.com/press/ryze-superfoods-drops-mushroom-coffee-and-matcha-health-claims-after-nad-inquiry 2025-09-24 https://www.asawaldstein.com/press/ahpa-leans-on-past-to-embrace-high-tech-future-at-botanical-congress 2025-09-22 https://www.asawaldstein.com/press/supplement-weight-management-claims-in-the-glp-1-era 2025-09-15 https://www.asawaldstein.com/press/q1-2025-warning-letter-roundup-with-asa-waldstein 2025-08-07 https://www.asawaldstein.com/press/formulating-for-quality 2025-08-05 https://www.asawaldstein.com/press/three-recently-filed-lawsuits-highlight-legal-risk-in-protein-labeling-compliance 2025-06-26 https://www.asawaldstein.com/press/regulators-mostly-silent-on-glp-1-supplement-claims 2025-06-09 https://www.asawaldstein.com/press/q1-2025-warning-letter-roundup-with-asa-waldstein 2025-04-16 https://www.asawaldstein.com/press/olly-and-brainpack-nad-decisions-highlight-challenges-in-supplement-advertising 2025-02-03 https://www.asawaldstein.com/press/cognitive-and-memory-warning-letters-and-litigation-trends%3A-best-practices-for-reducing-risk 2025-01-16 https://www.asawaldstein.com/press/q4-2024-warning-letter-roundup-with-asa-waldstein 2025-01-08 https://www.asawaldstein.com/press/the-buzz-in-natural%3A-december-2024 2024-12-04 https://www.asawaldstein.com/press/2025-state-of-the-industry 2024-12-04 https://www.asawaldstein.com/press/join-me-for-supplyside-west-workshop-on-nutritional-ingredient-claims%2C-legal-flames 2025-01-09 https://www.asawaldstein.com/press/q3-2024-warning-letter-roundup-with-asa-waldstein 2024-10-03 https://www.asawaldstein.com/press/ai-powered-tech-makes-customised-regulatory-compliance-possible 2024-08-20 https://www.asawaldstein.com/press/fda%2C-industry-experts-reflect-on-dshea-at-30-summit 2025-01-09 https://www.asawaldstein.com/press/30-supplement-industry-voices-suggest-changes-to-dshea 2025-01-09 https://www.asawaldstein.com/press/is-your-age-verification-process-in-place%3F-everything-you-need-to-know-about-selling-in-ny 2024-05-23 https://www.asawaldstein.com/press/revealed%3A-the-18-finalists-of-the-2024-vitafoods-europe-startup-innovation-challenge 2024-04-18 https://www.asawaldstein.com/press/q1-2024-warning-letter-roundup-with-asa-waldstein 2024-04-05 https://www.asawaldstein.com/press/celebrating-innovation 2024-02-27 https://www.asawaldstein.com/press/ftc-settles-with-supplement-startup-over-covid-claims 2024-02-26 https://www.asawaldstein.com/press/adapting-your-business-strategy-to-the-regulatory-outlook 2024-02-16 https://www.asawaldstein.com/press/what-can-you-say-in-weight-loss-claims%3F-experts-weigh-in 2024-01-22 https://www.asawaldstein.com/press/new-year%2C-same-problem%3A-fda-issues-tejocote-root-warning%2C-finding-the-supplements-adulterated-with-poisonous-plant 2024-01-04 https://www.asawaldstein.com/press/q%26a%3A-apex-compliance-founder-talks-streamlining-supplement-regulatory-marketing-compliance 2024-01-03 https://www.asawaldstein.com/press/q4-warning-letter-roundup-with-asa-waldstein 2024-01-02 https://www.asawaldstein.com/press/sales-soar-for-probiotic-containing-soft-drinks 2023-10-31 https://www.asawaldstein.com/press/q2-warning-letter-roundup-with-asa-waldstein 2023-10-11 https://www.asawaldstein.com/press/new-software-emerges-to-help-nutrition-and-dietary-supplement-companies-vet-marketing-claims 2023-08-10 https://www.asawaldstein.com/press/regulatory-compliance-software-helps-supplement%2C-nutrition%2C-functional-food%2C-and-cannabis-brands-vet-their-marketing-claims 2023-08-09 https://www.asawaldstein.com/press/fda-targets-ak-forte-distributor-for-selling-drugs%2C-not-supplements 2023-07-13 https://www.asawaldstein.com/press/q3-warning-letter-roundup-with-asa-waldstein 2023-10-11 https://www.asawaldstein.com/press/new-software-makes-in-house-regulatory-expertise-accessible 2023-07-11 https://www.asawaldstein.com/press/asa-waldstein-wins-ahpa-herbal-hero-award 2023-04-28 https://www.asawaldstein.com/press/ten-experts-reflect-on-state-of-u.s.-hemp-industry 2023-04-26 https://www.asawaldstein.com/press/cutting-edge-solutions-for-hemp-marketing 2023-04-24 https://www.asawaldstein.com/press/q1-warning-letter-roundup-with-asa-waldstein 2023-04-04 https://www.asawaldstein.com/press/hemp-and-cbd-industry-responds-to-fda%E2%80%99s-announcement-on-cbd 2023-02-01 https://www.asawaldstein.com/press/is-fda-watching-heart-health-supplements-in-2023%3F-2023-ingredient-trends-for-food%2C-drinks%2C-dietary-supplements%2C-and-natural-products 2023-01-24 https://www.asawaldstein.com/press/fda-warning-letters%2C-activity-and-actions-in-2022-and-what-that-means-for-2023 2023-01-20 https://www.asawaldstein.com/press/why-cbd-companies-should-re-examine-their-marketing-content----now 2023-01-18 https://www.asawaldstein.com/press/house-oversight-chair-to-fda%3A-enough-is-enough 2023-01-17 https://www.asawaldstein.com/press/q4-warning-letter-roundup-with-asa-waldstein 2022-12-20 https://www.asawaldstein.com/press/stay-in-your-lane%3A-novel-delivery-systems-must-comply-with-supplement-regulations 2022-11-23 https://www.asawaldstein.com/press/beauty-from-within-marketing%3A-best-practices-and-pitfalls-to-avoid 2022-11-18 https://www.asawaldstein.com/press/%E2%80%98warning-letter-geek%E2%80%99-decodes-marketing-compliance 2022-11-17 https://www.asawaldstein.com/press/regulatory-and-enforcement-update-on-notable-action-in-the-cognition%2C-adaptogen-%26-nootropic-space 2022-10-13 https://www.asawaldstein.com/press/common-practitioner-pitfalls-to-avoid-when-marketing-dietary-supplements 2022-11-01 https://www.asawaldstein.com/press/q3-warning-letter-roundup-with-asa-waldstein 2022-09-28 https://www.asawaldstein.com/press/compliance-responsibilities-when-using-a-contract-manufacturer 2022-09-12 https://www.asawaldstein.com/press/the-future-of-cbd-research%2C-marketing%2C-and-regulation 2022-08-01 https://www.asawaldstein.com/press/limiting-marketing-risk-for-hemp-and-cbd-products 2022-07-19 https://www.asawaldstein.com/press/ndi-warning-letters-fuel-criticism-of-fda-enforcement-approach%E2%80%94again 2022-06-02 https://www.asawaldstein.com/press/compliance-essentials-for-hemp-cbd-companies%2C-part-3-of-3%3A-marketing 2022-05-04 https://www.asawaldstein.com/press/mental-wellbeing-in-today's-digital-age 2022-05-03 https://www.asawaldstein.com/press/q2-fda-warning-letter-roundup-with-asa-waldstein 2022-05-04 https://www.asawaldstein.com/press/eu%E2%80%99s-new-thc-limits-for-hemp-based-products-will-%E2%80%98level-the-playing-field%E2%80%99-for-food-producers 2022-04-21 https://www.asawaldstein.com/press/white-whale-creations-newsletter 2022-04-07 https://www.asawaldstein.com/press/fda%2C-ftc-slap-cbd-industry-with-seven-warning-letters-related-to-covid-claims 2022-04-04 https://www.asawaldstein.com/press/compliance-essentials-for-hemp-cbd-companies-part-2-of-3 2022-04-04 https://www.asawaldstein.com/press/stress%3A-what-can-you-claim-on-a-product-label%3F 2022-03-17 https://www.asawaldstein.com/press/%23naturallyinformed-event-looks-at-immune-health-from-all-angles 2022-03-17 https://www.asawaldstein.com/press/q1-fda-warning-letter-roundup-with-asa-waldstein 2022-03-01 https://www.asawaldstein.com/press/compliance-essentials-for-hemp-cbd-companies-part-1-of-3 2022-03-23 https://www.asawaldstein.com/press/researchers%2C-hemp-leaders-caution-cannabis-producers-against-profiteering-on-early-covid-research 2022-01-28 https://www.asawaldstein.com/press/hemp-industry-2022-opportunities-report- 2022-03-28 https://www.asawaldstein.com/press/hemp-leaders-look-ahead-to-2022 2021-12-27 https://www.asawaldstein.com/press/product-reviews-%26-marketing-claims 2021-10-13 https://www.asawaldstein.com/press/fda-rejects-two-new-dietary-ingredient-submissions-for-cbd%2C-leaving-hemp-industry-with-legislation-as-only-route-to-clarity 2021-09-27 https://www.asawaldstein.com/press/fda-objects-to-cbd-being-sold-as-a-dietary-supplement%3B-industry-leaders-speak-out 2021-09-27 https://www.asawaldstein.com/press/influencers-and-cbd%3A-be-careful-what-you-say 2022-04-07 https://www.asawaldstein.com/press/fda-ups-the-ante-in-its-war-against-cbd 2021-09-27 https://www.asawaldstein.com/press/leaders-weigh-in-on-proposed-ny-state-rule 2021-09-27 https://www.asawaldstein.com/press/predictions-for-2021%3A-what's-ahead-for-the-hemp-sector 2021-09-27 https://www.asawaldstein.com/press/how-to-market-cbd-products-without-attracting-fda-warnings 2021-09-27 https://www.asawaldstein.com/press/ahpa-event-guides-cbd-industry 2021-09-27 https://www.asawaldstein.com/press/ftc-targets-cbd-marketers-in-law-enforcement-sweep 2021-09-27 https://www.asawaldstein.com/press/usda-final-hemp-rule-draws-mixed-reactions-from-industry-stakeholders 2021-09-27 https://www.asawaldstein.com/press/hiring-and-recruiting-practices 2021-09-27 https://www.asawaldstein.com/press/ftc%E2%80%99s-operation-cbdeceit-brings-action-against-cbd-companies 2021-09-27 https://www.asawaldstein.com/press/tips-for-lower-risk-marketing-supplements-%26-cbd-products-in-the-coronavirus-era 2021-09-27 https://www.asawaldstein.com/press/staying-on-the-right-side-of-regulators 2021-09-27 https://www.asawaldstein.com/press/ahpa-publishes-hemp-lexicon 2021-09-27 https://www.asawaldstein.com/press/carbon-footprint-labels-could-be-coming-to-cannabis 2021-09-27 https://www.asawaldstein.com/press/the-blurred-lines-of-the-legality-of-delta-8 2021-09-27 https://www.asawaldstein.com/press/the-complexities-of-marketing-hemp-products 2021-09-27